Emergent Epidemics Research with Dr. Amos Ndhere
by Dr. Amos Ndhere
The Emergent Epidemics Research Podcast, host Dr. Amos Ndhere interviews scientists, global health leaders, and medical experts at the forefront to reveal the latest cutting edge medical innovations to combat emerging infectious. Weekly’s newest episodes breakdown scientific, strategies, end-to-end operational delivery, and "How-To's" of successful global vaccine and drug clinical trials.
Episodes
-
The Next-Generation Mpox (MPXV) Vaccines: Current Progress and Future Outlook
Mpox virus (MPXV) is evolving. So is the science. In this presentation, I'll discuss the current mpox vaccine landscape and next-generation vaccines being developed to improve large-scale production and long-term efficacy. If successful, these next-gen vaccines will help the scientific community...
-
Evolutionary Dynamics of Mpox Virus Clades and Implications for Public Health
Mpox Virus has evolved into two distinct clades I and II, each with differing transmission rates and virulence. These clades raises new concerns about transmissibility and what it means for the future of Mpox control and vaccine efficacy. This episode highlights evolutionary dynamics of Mpox…
more -
Outsourcing Clinical Trials – Key Decision Guide
Outsourcing offers potential relief for pharmaceutical and biotechnology firms engaged in clinical trials. However, determining the most appropriate outsourcing approach presents challenges, consumes time, and carries inherent risks that could result in project failure. Reevaluating one's…
more -
The Art of Perfect Timing - A guide to Clinical Research Regulatory Success in 2024
The pharmaceutical industry suffers significant financial losses and delays market entry due to the overwhelming maze of clinical research regulatory requirements. Here is a 3-step roadmap to perfect the timing of regulatory submission for success: STEP 1. Identify Regulatory Authority. STEP 2:...
-
Why Regulatory Delays Could Be Catastrophic for Clinical Research
Clinical trials play a crucial role in developing new medical treatments and vaccines for public health. They are the stepping stones that bring hope to patients. Regulatory delays have significant consequences for the pharmaceutical industry and patients and their families who rely on timely R&D...
-
Why Africa Attracts Biopharmaceutical Clinical Trials
Clinical Trials in Africa: Opportunities & Benefits for Pharmaceutical Industry - PART 2 VIDEO In this two-part episode series, I will examine the trends, drivers, and opportunity windows that shape the African clinical industry market dynamics and why industry sponsors should consider Africa in...
-
Clinical Research Record Retention Guidelines
International Conference on Harmonization (ICH) Good Clinical Practice (E-6) requires investigators and sponsors to retain specific study records associated with the conduct of clinical research. These documents are often referred to as Essential Documents. 🎥 In this episode, I share insights...
-
High-Stake Impact of Clinical Regulatory Delays
Clinical trials play a crucial role in developing new medical treatments and vaccines. They are the stepping stones that bring hope to patients. Regulatory delays have significant consequences for the pharmaceutical industry and patients and their families who rely on timely R&D of new treatments...
-
How To Overcome Clinical Trial Regulatory Obstacles in Sub-Saharan Africa
As a pharmaceutical sponsor of clinical research, you want a seamless, efficient, and prompt regulatory submission, review, and approval for your next clinical trial. The challenge lies in the fact that the regulatory process may have its own pace. But what if you strategically aligned your…
more -
Non-sponsor Causes of Clinical Trial Regulatory Delays & Expert Tips to Navigate Them
This two-part episode reveals 12 common non-sponsor-related causes and reasons for clinical regulatory delays and offers expert insights and guidance on navigating them. Understanding these causes helps Sponsor teams to: Plan Regulatory Submission, Make informed GO/No-Go Decisions, Mitigate...
-
How to Supercharge Pharmaceutical R&D in an Outbreak Situation – PART 2
The R&D window during an outbreak is very short; in some cases, there is only a limited number of patients for experimental treatment. Pharmaceutical sponsors will struggle to complete the R&D of vaccines and treatments against global health biothreats in outbreak settings until they leverage...
-
How To Supercharge Pharmaceutical R&D During Outbreak - PART 1
Conducting vaccine and drug clinical trials during disease outbreaks can be a drag. Sponsors will struggle to deliver new products against global health biothreats unless they leverage lessons learned during previous studies to influence clinical research development plans during future…
more -
Clinical Trial Insurance: Guidelines and best practices in Sub-Saharan Africa
Regulatory authorities in Sub-Saharan Africa are scrutinizing pharmaceutical companies’ risk management and control practices with more rigor than ever before. Choosing the right insurance for human clinical trials can be difficult, especially in sub-Saharan Africa. Clinical trial sponsors must...
-
How to WIN $60 billion Africa's Pharmaceutical Market Share
Africa's pharmaceutical market is $60B, and CAGR is about 10%. Global pharmaceutical companies will struggle to break into the growing African market until they position pharmaceutical products correctly. In this video, I will explain how Medical Affairs can position products for the growing...
About this show
The Emergent Epidemics Research Podcast, host Dr. Amos Ndhere interviews scientists, global health leaders, and medical experts at the forefront to reveal the latest cutting edge medical innovations to combat emerging infectious. Weekly’s newest episodes breakdown scientific, strategies, end-to-end operational delivery, and "How-To's" of successful global vaccine and drug clinical trials.
Hosted by
Dr. Amos Ndhere